ArticleBMC microbiology2026
Comprehensive in vitro probiotic screening and ITS-based molecular identification and characterization of yeast strains isolated from agro-industrial and rumen sources.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProbiotic yeasts, particularly Saccharomyces cerevisiae, are receiving increasing attention for their health-promoting effects. However, identifying safe and efficient strains from diverse and underexplored ecological niches remains challenging. This study addressed this gap by isolating and characterizing yeast strains from agro-industrial byproducts and rumen-derived sources, followed by a comprehensive evaluation of their probiotic attributes and safety profiles.
methodsFifty-four yeast isolates were subjected to a multi-step in vitro screening workflow, including morphological assessment, safety evaluation (hemolytic, gelatinase, and DNase activities), gastrointestinal tolerance tests, cell surface characterization (hydrophobicity, auto-aggregation, co-aggregation), antimicrobial activity, antioxidant capacity, and antibiotic susceptibility. Molecular identification of selected strains was performed using ITS sequencing and phylogenetic analysis.
resultsA total of ten strains passed the primary safety and functional criteria. Among them, four top-performing isolates showed exceptional probiotic potential, exhibiting gastrointestinal survival rates > 80%, cell surface hydrophobicity > 80%, and co-aggregation with Escherichia coli ATCC 25922 > 70%. These isolates also produced antimicrobial inhibition zones > 12 mm and demonstrated DPPH radical scavenging activity > 80%. After excluding three antibiotic-resistant strains, nine final candidates were confirmed by PCR, comprising four S. cerevisiae and five Pichia fermentans strains.
conclusionsYeasts isolated from non-conventional agro-industrial and rumen-derived sources demonstrated strong in vitro probiotic properties and fulfilled essential safety requirements. These findings highlight their potential application as functional ingredients in food and feed formulations. Nevertheless, in vivo studies are required to validate their efficacy and safety in host systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.